Medicare Enrolled

Dr. Caesar Tin-U, MD

Hematology & Oncology · Sugar Land, TX
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Consulting-driven
1350 FIRST COLONY BLVD, Sugar Land, TX 77479
2812775200
In practice since 2006 (19 years)
NPI: 1609814615 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Tin-U from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Tin-U? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Tin-U

Dr. Caesar Tin-U is a hematology & oncology specialist in Sugar Land, TX, with 19 years of NPI registration. Based on federal Medicare data, Dr. Tin-U performed 15,278 Medicare services across 789 unique beneficiaries.

Between the years covered by Open Payments, Dr. Tin-U received a total of $5,522 from 14 pharmaceutical and/or device companies across 30 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Tin-U is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 35% volume in TX $5,522 industry payments

Medicare Practice Summary

Medicare Utilization ↗
15,278
Medicare services
Top 35% in TX for hematology & oncology
789
Unique beneficiaries
$6
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~804 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Anti-nausea injection (fosaprepitant)
An injection of fosaprepitant, a medication used to prevent nausea and vomiting.
7,500 $0 $5
Contrast dye for imaging (iodine-based)
A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures.
3,900 $0 $3
Dexamethasone injection (steroid)
An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram.
890 $0 $1
Anti-nausea injection (Aloxi/palonosetron) 570 $1 $114
Injection, granisetron hydrochloride, 100 mcg 500 $0 $24
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
326 $8 $20
Complete blood count (CBC) with differential
An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells.
317 $8 $36
Additional sequential IV infusion, 1 hour or less
This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less.
151 $20 $157
Intravenous chemotherapy infusion, 1 hour or less
Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete.
138 $95 $707
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
125 $57 $250
Intensity-modulated radiation therapy delivery
Delivery of radiation therapy using narrow beams that are spatially and temporally modulated to target specific areas. This process is performed per treatment session.
120 $267 $2,762
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
116 $83 $368
Intravenous injection of additional new drug or substance
Administration of an additional new medication or substance directly into a vein.
94 $11 $108
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
82 $62 $247
Intravenous infusion, 1 hour or less
Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less.
66 $43 $313
Intravenous infusion of new drug or substance, 1 hour or less
This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less.
57 $45 $344
Additional hour of intravenous chemotherapy
This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period.
55 $19 $161
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
45 $11 $96
Additional hour of intravenous hydration
This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy.
40 $10 $75
CT scan of chest with contrast
A computed tomography scan of the chest using a contrast dye to enhance the visibility of internal structures.
37 $34 $821
Diphenhydramine injection, up to 50 mg
An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams.
37 $1 $7
CT scan of abdomen and pelvis with contrast
A CT scan that uses dye to create detailed images of the abdomen and pelvis. This imaging test helps doctors examine internal organs and structures in these areas.
34 $138 $1,067
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
23 $134 $694
Reticulated platelet measurement
A blood test that measures the level of young, newly formed platelets in the body.
22 $35 $143
Irrigation of implanted venous access device
This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids.
21 $16 $114
New patient office visit, complex (60-74 min) 12 $145 $709
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
2.7% high complexity
90.2% medium
7.1% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$5,522
Total received (2018-2024)
Avg $789/year across 7 years
Top 42% in TX for hematology & oncology
14
Companies
30
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$4,567 (82.7%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$754 (13.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$201 (3.6%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$117
2023
$149
2022
$265
2021
$13
2020
$27
2019
$4,748
2018
$202

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Janssen Scientific Affairs, LLC
$4,638
Astellas Pharma US Inc
$206
E.R. Squibb & Sons, L.L.C.
$122
Heron Therapeutics, Inc.
$107
Bayer HealthCare Pharmaceuticals Inc.
$101
Novartis Pharmaceuticals Corporation
$94
PFIZER INC.
$86
Tempus AI, Inc
$44
Exelixis Inc.
$38
Eisai Inc.
$29
BeiGene USA, Inc.
$23
Janssen Biotech, Inc.
$19
Amgen Inc.
$13
Janssen Pharmaceuticals, Inc
$2
Top 3 companies account for 89.9% of total payments
Associated products mentioned in payments ›
BRUKINSA · Cabometyx · Erleada · IBRANCE · IMBRUVICA · KISQALI · Lenvima · PROMACTA · REBLOZYL · SCEMBLIX · SUSTOL · TALZENNA · Vitrakvi · XARELTO · XTANDI
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (83%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers.

Equivalent to $36 per 100 Medicare services performed
Looking for a hematology & oncology specialist in Sugar Land?
Compare hematology & oncology specialists in the Sugar Land area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncology specialists nearby

Geographic Context

Hematology & oncology specialists within 10 mi
184
Per 100K population
21.4
County median income
$113,409
Nearest hospital
HOUSTON METHODIST SUGARLAND HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Tin-U is a mixed practice specialist, with moderate Medicare volume, with consulting-driven industry engagement, with 19 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Tin-U experienced with anti-nausea injection (fosaprepitant)?
Based on Medicare claims data, Dr. Tin-U performed 7,500 anti-nausea injection (fosaprepitant) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Tin-U receive payments from pharmaceutical companies?
Yes. Dr. Tin-U received a total of $5,522 from 14 companies across 30 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Tin-U's costs compare to other hematology & oncology specialists in Sugar Land?
Dr. Tin-U's average Medicare payment per service is $6. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Tin-U) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →